iBio Inc (IBIO): It’s a new company started in 2017 R...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

iBio Inc (IBIO)

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	7
Posts	967
Boards Moderated	0
Alias Born	12/18/2018

Re: None

Wednesday, 03/11/2020 8:44:33 AM

Wednesday, March 11, 2020 8:44:33 AM

It’s a new company started in 2017

Ruicheng Haihui
Beijing Ruicheng Haihui Health Technology Co., Ltd. is a new and innovative enterprise specializing in biomedical technology research and product development. Based on plant bioreactor technology, the company researches and develops a variety of biomedical and recombinant protein products.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent IBIO News

Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 09:03:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 11:29:19 AM
iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance • GlobeNewswire Inc. • 10/30/2025 11:00:00 AM
iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference • GlobeNewswire Inc. • 10/23/2025 11:00:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/22/2025 10:29:45 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/22/2025 10:28:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/22/2025 10:27:17 PM
iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025 • GlobeNewswire Inc. • 10/21/2025 11:00:00 AM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/06/2025 09:19:16 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:15:58 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/05/2025 01:30:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2025 01:00:29 PM
iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 09/05/2025 11:30:00 AM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/25/2025 09:20:11 PM
iBio Announces Closing of $50 Million Public Offering • GlobeNewswire Inc. • 08/25/2025 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2025 08:11:41 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/21/2025 08:07:10 PM
iBio Announces Pricing of $50 Million Public Offering • GlobeNewswire Inc. • 08/19/2025 12:01:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2025 08:24:08 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/18/2025 08:21:08 PM
iBio Announces Proposed Public Offering • GlobeNewswire Inc. • 08/18/2025 08:01:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2025 08:47:29 PM

More IBIO News

InvestorsHub NewsWire

ECGI Highlights Fintech Expansion Through RezyFi Acquisition and Tokenized Mortgage Platform in Shareholder Letter • ECGI • Nov 11, 2025 8:30 AM

The New Gold Rush of the AI Era • ESAU • Nov 10, 2025 9:00 AM

The Energy Breakthrough That Could Power the AI Era • TSLA • Nov 10, 2025 9:00 AM

Isiah Thomas Marks Historic Milestone: First NBA Player With Majority Control of a Public Company • OWPC • Nov 6, 2025 12:23 PM

EVTV Takes Flight in Europe: U.S. Heavy-Lift Drones to Disrupt Traditional Vineyard Operations Across Italy • EVTV • Nov 6, 2025 8:19 AM

Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment • AVAI • Nov 4, 2025 8:46 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow